Key facts
- This page summarizes Soheil Shams's Form 5 filing for Bionano Genomics, Inc. (BNGO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 11 Feb 2022, 17:05.
Soheil Shams - 31 Dec 2021 Form 5 Insider Report for Bionano Genomics, Inc. (BNGO)
- Reporting relationship
- Chief Informatics Officer
- Issuer ticker
- BNGO
- Reported as of
- 31 Dec 2021
- Net transaction value
- $0
- SEC form
- 5
- Accepted by SEC
- 11 Feb 2022, 17:05:49 UTC
- Prior SEC filing
- 02 Nov 2021
- Next SEC filing
- 15 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ R. Erik Holmlin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Soheil Shams filed Form 5 for Bionano Genomics, Inc. (BNGO) on 11 Feb 2022.
Change
- Previous filing in this sequence was filed on 02 Nov 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 5 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BNGO
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -318,899
- Change %
- -6%
- Price
- $0.000000
- Shares after
- 5,006,479
- Date
- 30 Dec 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.